Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach
Antiphospholipid Antibodies Activate mTORC in Vessels
Research around autoimmune disorder shows patients may respond to treatment with sirolimus
Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus
Research collaboration among scientists, pharmaceutical companies, nonprofits promotes precompetitive sharing of data collection, analyses
Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data
Plus, rheumatology drug news, safety updates
EULAR 2014: Cardiac Involvement in Rheumatic Diseases
Experts offer tips for treating, managing cardiac effects; using cardiac magnetic resonance imaging in patients chronic inflammatory conditions
Inflammatory Origin of Fever Is Key to Diagnosis
Fever in rheumatology patients may present evidence of an inflammatory process
Autoimmune Myelofibrosis: A Case Review
Diagnosis, treatment and management of AMF in Hispanic patient with lupus
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus
The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals
Rheumatology’s premier event to be held in Boston from Nov. 14–19
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 43
- Next Page »